-
Je něco špatně v tomto záznamu ?
T-Cell Activation: Post-Infection Diagnostic Tool for COVID-19
P. Simara, L. Tesarova, I. Tapuchova, J. Celerova, I. Koutna
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články
NLK
Free Medical Journals
od 2000
Freely Accessible Science Journals
od 2000
ProQuest Central
od 2005-01-01
Health & Medicine (ProQuest)
od 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2000
- MeSH
- aktivace lymfocytů MeSH
- COVID-19 * MeSH
- lidé MeSH
- protilátky virové MeSH
- SARS-CoV-2 MeSH
- T-lymfocyty MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
COVID-19 is caused by the SARS-CoV-2 virus and has spread globally in 2020. Cellular immunity may serve as an important functional marker of the disease, especially in the asymptomatic cases. Blood samples were collected from 46 convalescent donors with a history of COVID-19 and 38 control donors. Quantification of the T-cell response upon contact with SARS-CoV-2 proteins in vitro was based on IFN-γ. Significantly higher numbers of activated cells were measured in patients who underwent COVID-19. Anti-SARS-CoV-2 T cells were detected weeks after the active virus disappeared from the organism. Repeated sample collection after five months proved that the T-cell activation was weaker in time in 79 % of the patients. In the majority of cases, the CD4+ helper T-cell subpopulation was responsible for the immune reaction. Moreover, different viral proteins triggered activation in CD4+ helper and in CD8+ cytotoxic T cells. Together, these findings suggest that the T-cell activation level identifies the individuals who underwent COVID-19 and may become a diagnostic tool for the disease.
Department of Histology and Embryology Faculty of Medicine Masaryk University Brno Czech Republic
International Clinical Research Center of St Anne's University Hospital in Brno Brno Czech Republic
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21017471
- 003
- CZ-PrNML
- 005
- 20211012111744.0
- 007
- ta
- 008
- 210723s2021 xr d f 000 0|eng||
- 009
- AR
- 035 __
- $a (PubMed)34273263
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Šimara, Pavel $u International Clinical Research Center of St. Anne's University Hospital in Brno, Brno, Czech Republic $u Department of Histology and Embryology, Faculty of Medicine, Masaryk University, Brno, Czech Republic $7 xx0221260
- 245 10
- $a T-Cell Activation: Post-Infection Diagnostic Tool for COVID-19 / $c P. Simara, L. Tesarova, I. Tapuchova, J. Celerova, I. Koutna
- 520 9_
- $a COVID-19 is caused by the SARS-CoV-2 virus and has spread globally in 2020. Cellular immunity may serve as an important functional marker of the disease, especially in the asymptomatic cases. Blood samples were collected from 46 convalescent donors with a history of COVID-19 and 38 control donors. Quantification of the T-cell response upon contact with SARS-CoV-2 proteins in vitro was based on IFN-γ. Significantly higher numbers of activated cells were measured in patients who underwent COVID-19. Anti-SARS-CoV-2 T cells were detected weeks after the active virus disappeared from the organism. Repeated sample collection after five months proved that the T-cell activation was weaker in time in 79 % of the patients. In the majority of cases, the CD4+ helper T-cell subpopulation was responsible for the immune reaction. Moreover, different viral proteins triggered activation in CD4+ helper and in CD8+ cytotoxic T cells. Together, these findings suggest that the T-cell activation level identifies the individuals who underwent COVID-19 and may become a diagnostic tool for the disease.
- 650 _2
- $a protilátky virové $7 D000914
- 650 12
- $a COVID-19 $7 D000086382
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a aktivace lymfocytů $7 D008213
- 650 _2
- $a SARS-CoV-2 $7 D000086402
- 650 _2
- $a T-lymfocyty $7 D013601
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Tesařová, Lenka $u International Clinical Research Center of St. Anne's University Hospital in Brno, Brno, Czech Republic $u Department of Histology and Embryology, Faculty of Medicine, Masaryk University, Brno, Czech Republic $7 xx0264773
- 700 1_
- $a Tapuchova, I $u International Clinical Research Center of St. Anne's University Hospital in Brno, Brno, Czech Republic $u Department of Histology and Embryology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Celerová, Jarmila, $u International Clinical Research Center of St. Anne's University Hospital in Brno, Brno, Czech Republic $d 1965- $7 xx0104761
- 700 1_
- $a Koutná, Irena $u International Clinical Research Center of St. Anne's University Hospital in Brno, Brno, Czech Republic $u Department of Histology and Embryology, Faculty of Medicine, Masaryk University, Brno, Czech Republic $7 _AN070729
- 773 0_
- $w MED00011004 $t Folia biologica $x 0015-5500 $g Roč. 67, č. 1 (2021), s. 16-27
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34273263 $y Pubmed
- 856 41
- $u https://fb.cuni.cz/file/5943/fb2021a0003.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b A 970 $c 89 $y p $z 0
- 990 __
- $a 20210723 $b ABA008
- 991 __
- $a 20211012111740 $b ABA008
- 999 __
- $a ok $b bmc $g 1701387 $s 1137913
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 67 $c 1 $d 16-27 $e - $i 0015-5500 $m Folia biologica (Praha) $n Folia biol. (Praha) $x MED00011004
- LZP __
- $b NLK138 $a Pubmed-20210723